← Back to headlines
Arcturus outlines 12-week Phase II CF trial launch and expects regulatory clarity for ARCT-810 in 2026
4 Mar, 04:15 — 4 Mar, 04:15
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
The emergency kit is a hit with Belgians: "A new wave is coming"
6m ago
Dutch Michelin Star chef was way over alcohol limit when he drove into colleague: Expert
20m ago
Limit on sperm donations: Donor child asks: "How many are we really?"
22m ago
Ask The Doctor: I used to get heartburn after spicy foods and now it is after any food. Should I be worried?
24m ago